Hudock Inc’s BioLife Solutions BLFS Stock Holding History

Hudock Inc’s Portfolio BLFS Stock Details BLFS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-43	Closed	–	–	640
2018 Q3	$0	Hold	43	–	–	﹤0.01%	674
2018 Q2	$0	Hold	43	–	–	﹤0.01%	658
2018 Q1	$0	Hold	43	–	–	﹤0.01%	652
2017 Q4	$0	Hold	43	–	–	﹤0.01%	634
2017 Q3	$0	Hold	43	–	–	﹤0.01%	635
2017 Q2	$0	Hold	43	–	–	﹤0.01%	601
2017 Q1	$0	Hold	43	–	–	﹤0.01%	560
2016 Q4	$0	Hold	43	–	–	﹤0.01%	554
2016 Q3	$0	Hold	43	–	–	﹤0.01%	566
2016 Q2	$0	Hold	43	–	–	﹤0.01%	587
2016 Q1	$0	Hold	43	–	–	﹤0.01%	584
2015 Q4	$0	Hold	43	–	–	﹤0.01%	549
2015 Q3	$0	Hold	43	–	–	﹤0.01%	572
2015 Q2	$0	Hold	43	–	–	﹤0.01%	569
2015 Q1	$0	Hold	43	–	–	﹤0.01%	594
2014 Q4	$0	Hold	43	–	–	﹤0.01%	545
2014 Q3	$0	Hold	43	–	–	﹤0.01%	582
2014 Q2	$0	Buy	+43	New	+$116	﹤0.01%	584

Other funds holding BLFS

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

SCM

Sandler Capital Management New York $193M AUM 77.14% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

EIM

Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

CCM

Cadence Capital Management Boston, Massachusetts $415M AUM 11.01% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Hudock Inc's BLFS Position: Q4 2018 in Review

Hudock Inc sold out of BioLife Solutions (BLFS) in Q4 2018, closing a stake of 43 shares.

Hudock Inc first reported a position in BLFS in Q2 2014 and held it in 18 quarters. The position peaked at $0 in Q3 2018. 54 funds tracked by Wall St. Rank hold BLFS as of Q4 2018.

Hudock Inc reported no remaining BioLife Solutions position as of Q4 2018 after selling out during the quarter.
Hudock Inc sold 43 BioLife Solutions shares in Q4 2018.
Hudock Inc first reported a position in BioLife Solutions in Q2 2014 and held it in 18 quarters.
Hudock Inc's BioLife Solutions position peaked at $0 in Q3 2018.
54 funds tracked by Wall St. Rank held BioLife Solutions as of Q4 2018.

Based on Hudock Inc's 13F filing for Q4 2018, filed 29 Jan 2019.